Researchers have developed a hydrogel scaffold for craniofacial bone tissue regeneration that starts as a liquid, solidifies into a gel in the body, and liquefies again for removal, according to a new study in Biomacromolecules (December 10, 2013).
The material, developed by bioengineers at Rice University in Houston, is a soluble liquid at room temperature that can be injected to the point of need, according to a university press release.
At body temperature, the material instantly turns into a gel to help direct the formation of new bone to replace that damaged by injury or disease. The gel conforms to irregular three-dimensional spaces and provides a platform for functional and aesthetic tissue regeneration. It is intended as an alternative to prefabricated implantable scaffolds.
The new technology leverages injectable, thermally responsive, chemically cross-linkable, and bioresorbable hydrogels for regenerative medicine applications, said bioengineer Antonios Mikos, PhD. It enables the formation of scaffolds locally and the delivery of growth factors and stem cells into defects of complex anatomical shapes with minimal surgical intervention.
Thermosensitive technologies are not new to the field of tissue engineering and regenerative medicine, Mikos said. What makes the poly(N-isopropylacrylamide), or PNiPAAm, scaffold promising is that its chemical cross-linking technology allows researchers to eliminate gel shrinkage without reducing swelling, improving its stability so that it serves as an effective delivery vehicle for growth factors and stem cell populations.
Once sufficient quality and quantity of bone tissue have regenerated to fill the defected site, the hydrogel scaffold can be transitioned back into a liquid state and released naturally, according to the researchers.
As part of the project, the researchers will test the hydrogel's enhanced seeding capabilities and ability to promote cellular attachment, cross talk, and proliferation toward greater bone formation. The knowledge will improve the understanding of biomaterial-based therapies for minimally invasive tissue regeneration as viable clinical alternatives.
"The results demonstrate the ability to encapsulate stem cell populations with temperature-sensitive gelling scaffolds for injectable cell delivery with enormous implications for the development of novel therapeutics for craniofacial bone regeneration," Mikos said.
